Healthcare AI startup Qritive bags US$7.5m funding for new markets expansion
Add BT as a preferred sourceJanice Tan
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SINGAPORE-headquartered healthcare AI startup Qritive has raised US$7.5 million in a funding round led by MassMutal Ventures, supported by Enterprise Singapore’s investment arm Seeds Capital, and Exfinity Venture Partners.
The new capital will be used to drive geographical expansion, expand product portfolio and support regulatory clearances.
Founded in 2017 with operations in San Diego in the US and Pune in India, Qritive is an AI (artificial intelligence) solution developer that aims to advance digital pathology for cancer diagnosis, enhance imaging accuracy and improve health outcomes.
Its Pantheon digital pathology platform comprises tools for aspects including case management, reporting as well as slide viewing and analysis.
According to Qritive, its goal is to create an open-pathology environment as well as help make cancer diagnosis fast, accurate and affordable.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
